Related Experiment Video
Updated: Jun 25, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Microbiotas from extremely preterm infants with growth faltering impair postnatal growth and metabolism in mice
Kwai Tei Chan Poon1, Se Hyang Han1, Olga Ilkayeva2,3
1Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
Insights
Altered gut microbiota in preterm infants with poor growth impairs development. Modifying the intestinal microbiota in mice with poor growth restored normal postnatal growth, suggesting a therapeutic target.
Area of Science:
- Microbiology
- Neonatal Development
- Gastroenterology
Background:
- Postnatal growth faltering is common in extremely preterm infants and linked to poor neurodevelopment.
- Preterm infants with poor growth exhibit altered intestinal microbiota development compared to those with appropriate growth.
Purpose of the Study:
- To investigate if differences in intestinal microbiota development independently contribute to postnatal growth faltering in extremely preterm infants.
- To explore the potential of microbiota modification as a therapeutic strategy for growth impairment.
Main Methods:
- Gnotobiotic mice were colonized with intestinal microbiotas from extremely preterm infants with either poor or appropriate growth.
- Metabolic profiles, including hepatic acylcarnitines and circulating ketones, were analyzed to assess lipolysis and fatty acid oxidation.
- Intervention studies involved postnatal treatment with microbiotas from infants with appropriate growth in mice previously colonized with microbiotas from infants with poor growth.
Main Results:
- Colonization of neonatal mice with microbiotas from preterm infants with poor growth resulted in postnatal growth impairment.
- This impairment was associated with a metabolic signature of enhanced lipolysis and fatty acid oxidation.
- Postnatal microbiota treatment with samples from infants with appropriate growth successfully prevented growth impairment in affected mice.
Conclusions:
- Altered intestinal microbiota development is a contributing factor to postnatal growth faltering in extremely preterm infants.
- Microbiota modification holds promise as a strategy to restore normal postnatal growth in this vulnerable population.
Abstract:
Postnatal growth faltering is a pervasive problem among extremely preterm infants that is independently associated with adverse neurodevelopmental outcomes. We previously observed that preterm infants with poor postnatal growth have altered development of the intestinal microbiota relative to preterm infants with appropriate postnatal growth. Here, we used gnotobiotic mice to investigate whether these differences in microbiota development independently contribute to growth faltering. We found that colonization of neonatal mice with microbiotas from extremely preterm infants with poor growth reproduced postnatal growth impairment and induced a metabolic signature of enhanced lipolysis and fatty acid oxidation in the mice, characterized by elevated hepatic acylcarnitines and circulating ketones. In mice colonized at birth with microbiotas from infants with poor growth, postnatal treatment with microbiotas from infants with appropriate growth prevented growth impairment. These results indicate that altered development of the intestinal microbiota contributes to growth faltering in extremely preterm infants and that microbiota modification can restore postnatal growth.
Related Concept Videos
Development of Human Microbiota
Microbiota Modulation by Antibiotics
Development of the Oral Microbiota
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Introduction to the Human Microbiota
Gut-Brain Axis

